pH	O
-	O
Dependent	O
Transmembrane	B:C1148560
Activity	I:C1148560
of	O
Peptide	O
-	O
Functionalized	O
Gold	O
Nanostars	I:C0018026
for	O
Computed	O
Tomography	I:C0040405
/	O
Photoacoustic	O
Imaging	I:C3897929
and	O
Photothermal	O
Therapy	I:C0454527
.	O

pH	O
-	O
Dependent	O
Transmembrane	O
Activity	I:C1148560
of	O
Peptide	B:C0030956
-	O
Functionalized	O
Gold	O
Nanostars	I:C0018026
for	O
Computed	O
Tomography	I:C0040405
/	O
Photoacoustic	O
Imaging	I:C3897929
and	O
Photothermal	O
Therapy	I:C0454527
.	O

pH	O
-	O
Dependent	O
Transmembrane	O
Activity	I:C1148560
of	O
Peptide	O
-	O
Functionalized	O
Gold	B:C0018026
Nanostars	I:C0018026
for	O
Computed	O
Tomography	I:C0040405
/	O
Photoacoustic	O
Imaging	I:C3897929
and	O
Photothermal	O
Therapy	I:C0454527
.	O

pH	O
-	O
Dependent	O
Transmembrane	O
Activity	I:C1148560
of	O
Peptide	O
-	O
Functionalized	O
Gold	O
Nanostars	I:C0018026
for	O
Computed	B:C0040405
Tomography	I:C0040405
/	O
Photoacoustic	O
Imaging	I:C3897929
and	O
Photothermal	O
Therapy	I:C0454527
.	O

pH	O
-	O
Dependent	O
Transmembrane	O
Activity	I:C1148560
of	O
Peptide	O
-	O
Functionalized	O
Gold	O
Nanostars	I:C0018026
for	O
Computed	O
Tomography	I:C0040405
/	O
Photoacoustic	B:C3897929
Imaging	I:C3897929
and	O
Photothermal	O
Therapy	I:C0454527
.	O

pH	O
-	O
Dependent	O
Transmembrane	O
Activity	I:C1148560
of	O
Peptide	O
-	O
Functionalized	O
Gold	O
Nanostars	I:C0018026
for	O
Computed	O
Tomography	I:C0040405
/	O
Photoacoustic	O
Imaging	I:C3897929
and	O
Photothermal	B:C0454527
Therapy	I:C0454527
.	O

Progress	O
in	O
multifunctional	O
nanomaterials	O
for	O
tumor	B:C0920425
therapy	I:C0920425
mostly	O
depends	O
on	O
the	O
development	O
of	O
tumor	O
-	O
targeting	O
delivery	O
strategies	I:C0087111
.	O

Progress	O
in	O
multifunctional	O
nanomaterials	O
for	O
tumor	O
therapy	I:C0920425
mostly	O
depends	O
on	O
the	O
development	O
of	O
tumor	B:C0027651
-	O
targeting	O
delivery	O
strategies	I:C0087111
.	O

Progress	O
in	O
multifunctional	O
nanomaterials	O
for	O
tumor	O
therapy	I:C0920425
mostly	O
depends	O
on	O
the	O
development	O
of	O
tumor	O
-	O
targeting	O
delivery	B:C0087111
strategies	I:C0087111
.	O

A	O
novel	O
class	O
of	O
pH	B:C2606266
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
)	O
with	O
pH	O
-	O
dependent	O
transmembrane	O
activity	I:C1148560
can	O
fold	O
and	O
rapidly	O
insert	O
into	O
the	O
lipid	O
bilayer	I:C0023768
of	O
tumor	O
cells	I:C0597032
triggered	O
by	O
acidity	O
,	O
facilitating	O
the	O
cellular	O
internalization	O
of	O
nanomaterials	O
synchronously	O
.	O

A	O
novel	O
class	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
pH	B:C2606266
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
)	O
with	O
pH	O
-	O
dependent	O
transmembrane	O
activity	I:C1148560
can	O
fold	O
and	O
rapidly	O
insert	O
into	O
the	O
lipid	O
bilayer	I:C0023768
of	O
tumor	O
cells	I:C0597032
triggered	O
by	O
acidity	O
,	O
facilitating	O
the	O
cellular	O
internalization	O
of	O
nanomaterials	O
synchronously	O
.	O

A	O
novel	O
class	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
)	O
with	O
pH	O
-	O
dependent	O
transmembrane	B:C1148560
activity	I:C1148560
can	O
fold	O
and	O
rapidly	O
insert	O
into	O
the	O
lipid	O
bilayer	I:C0023768
of	O
tumor	O
cells	I:C0597032
triggered	O
by	O
acidity	O
,	O
facilitating	O
the	O
cellular	O
internalization	O
of	O
nanomaterials	O
synchronously	O
.	O

A	O
novel	O
class	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
)	O
with	O
pH	O
-	O
dependent	O
transmembrane	O
activity	I:C1148560
can	O
fold	B:C0332462
and	O
rapidly	O
insert	O
into	O
the	O
lipid	O
bilayer	I:C0023768
of	O
tumor	O
cells	I:C0597032
triggered	O
by	O
acidity	O
,	O
facilitating	O
the	O
cellular	O
internalization	O
of	O
nanomaterials	O
synchronously	O
.	O

A	O
novel	O
class	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
)	O
with	O
pH	O
-	O
dependent	O
transmembrane	O
activity	I:C1148560
can	O
fold	O
and	O
rapidly	O
insert	O
into	O
the	O
lipid	B:C0023768
bilayer	I:C0023768
of	O
tumor	O
cells	I:C0597032
triggered	O
by	O
acidity	O
,	O
facilitating	O
the	O
cellular	O
internalization	O
of	O
nanomaterials	O
synchronously	O
.	O

A	O
novel	O
class	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
)	O
with	O
pH	O
-	O
dependent	O
transmembrane	O
activity	I:C1148560
can	O
fold	O
and	O
rapidly	O
insert	O
into	O
the	O
lipid	O
bilayer	I:C0023768
of	O
tumor	B:C0597032
cells	I:C0597032
triggered	O
by	O
acidity	O
,	O
facilitating	O
the	O
cellular	O
internalization	O
of	O
nanomaterials	O
synchronously	O
.	O

Here	O
,	O
we	O
innovatively	O
decorated	O
gold	B:C0018026
nanostars	I:C0018026
(	O
gold	O
nanostars	I:C0018026
)	O
with	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
GNS	O
-	O
pHLIP	O
)	O
to	O
improve	O
their	O
targeting	O
ability	O
and	O
photothermal	O
therapeutic	I:C0454527
(	O
photothermal	O
therapeutic	I:C0454527
)	O
efficiency	O
.	O

Here	O
,	O
we	O
innovatively	O
decorated	O
gold	O
nanostars	I:C0018026
(	O
gold	B:C0018026
nanostars	I:C0018026
)	O
with	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
GNS	O
-	O
pHLIP	O
)	O
to	O
improve	O
their	O
targeting	O
ability	O
and	O
photothermal	O
therapeutic	I:C0454527
(	O
photothermal	O
therapeutic	I:C0454527
)	O
efficiency	O
.	O

Here	O
,	O
we	O
innovatively	O
decorated	O
gold	O
nanostars	I:C0018026
(	O
gold	O
nanostars	I:C0018026
)	O
with	O
pH	B:C2606266
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
GNS	O
-	O
pHLIP	O
)	O
to	O
improve	O
their	O
targeting	O
ability	O
and	O
photothermal	O
therapeutic	I:C0454527
(	O
photothermal	O
therapeutic	I:C0454527
)	O
efficiency	O
.	O

Here	O
,	O
we	O
innovatively	O
decorated	O
gold	O
nanostars	I:C0018026
(	O
gold	O
nanostars	I:C0018026
)	O
with	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
GNS	B:C0018026
-	O
pHLIP	O
)	O
to	O
improve	O
their	O
targeting	O
ability	O
and	O
photothermal	O
therapeutic	I:C0454527
(	O
photothermal	O
therapeutic	I:C0454527
)	O
efficiency	O
.	O

Here	O
,	O
we	O
innovatively	O
decorated	O
gold	O
nanostars	I:C0018026
(	O
gold	O
nanostars	I:C0018026
)	O
with	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
GNS	O
-	O
pHLIP	B:C2606266
)	O
to	O
improve	O
their	O
targeting	O
ability	O
and	O
photothermal	O
therapeutic	I:C0454527
(	O
photothermal	O
therapeutic	I:C0454527
)	O
efficiency	O
.	O

Here	O
,	O
we	O
innovatively	O
decorated	O
gold	O
nanostars	I:C0018026
(	O
gold	O
nanostars	I:C0018026
)	O
with	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
GNS	O
-	O
pHLIP	O
)	O
to	O
improve	O
their	O
targeting	O
ability	O
and	O
photothermal	B:C0454527
therapeutic	I:C0454527
(	O
photothermal	O
therapeutic	I:C0454527
)	O
efficiency	O
.	O

Here	O
,	O
we	O
innovatively	O
decorated	O
gold	O
nanostars	I:C0018026
(	O
gold	O
nanostars	I:C0018026
)	O
with	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
(	O
GNS	O
-	O
pHLIP	O
)	O
to	O
improve	O
their	O
targeting	O
ability	O
and	O
photothermal	O
therapeutic	I:C0454527
(	O
photothermal	B:C0454527
therapeutic	I:C0454527
)	O
efficiency	O
.	O

The	O
obtained	O
GNS	B:C0018026
-	O
pHLIP	O
exhibited	O
the	O
excellent	O
characteristics	O
of	O
uniform	O
size	O
and	O
good	O
biocompatibility	O
.	O

The	O
obtained	O
GNS	O
-	O
pHLIP	B:C2606266
exhibited	O
the	O
excellent	O
characteristics	O
of	O
uniform	O
size	O
and	O
good	O
biocompatibility	O
.	O

The	O
obtained	O
GNS	O
-	O
pHLIP	O
exhibited	O
the	O
excellent	O
characteristics	O
of	O
uniform	O
size	B:C0456389
and	O
good	O
biocompatibility	O
.	O

As	O
compared	O
to	O
GNS	B:C0018026
-	O
mPEG	O
,	O
the	O
cellular	O
internalization	O
of	O
GNS	O
-	O
pHLIP	O
was	O
1	O
-	O
fold	O
higher	O
after	O
a	O
2	O
h	O
incubation	O
with	O
cells	O
in	O
media	O
at	O
pH	O
6.4	O
than	O
at	O
pH	O
7.4	O
.	O

As	O
compared	O
to	O
GNS	O
-	O
mPEG	B:C0066763
,	O
the	O
cellular	O
internalization	O
of	O
GNS	O
-	O
pHLIP	O
was	O
1	O
-	O
fold	O
higher	O
after	O
a	O
2	O
h	O
incubation	O
with	O
cells	O
in	O
media	O
at	O
pH	O
6.4	O
than	O
at	O
pH	O
7.4	O
.	O

As	O
compared	O
to	O
GNS	O
-	O
mPEG	O
,	O
the	O
cellular	O
internalization	O
of	O
GNS	B:C0018026
-	O
pHLIP	O
was	O
1	O
-	O
fold	O
higher	O
after	O
a	O
2	O
h	O
incubation	O
with	O
cells	O
in	O
media	O
at	O
pH	O
6.4	O
than	O
at	O
pH	O
7.4	O
.	O

As	O
compared	O
to	O
GNS	O
-	O
mPEG	O
,	O
the	O
cellular	O
internalization	O
of	O
GNS	O
-	O
pHLIP	B:C2606266
was	O
1	O
-	O
fold	O
higher	O
after	O
a	O
2	O
h	O
incubation	O
with	O
cells	O
in	O
media	O
at	O
pH	O
6.4	O
than	O
at	O
pH	O
7.4	O
.	O

As	O
compared	O
to	O
GNS	O
-	O
mPEG	O
,	O
the	O
cellular	O
internalization	O
of	O
GNS	O
-	O
pHLIP	O
was	O
1	O
-	O
fold	O
higher	O
after	O
a	O
2	O
h	O
incubation	O
with	O
cells	B:C0007634
in	O
media	O
at	O
pH	O
6.4	O
than	O
at	O
pH	O
7.4	O
.	O

Moreover	O
,	O
the	O
tumor	B:C0027651
accumulation	O
of	O
the	O
GNS	O
-	O
pHLIP	O
was	O
3	O
-	O
fold	O
higher	O
than	O
that	O
of	O
GNS	O
-	O
mPEG	O
after	O
intravenous	O
injection	O
into	O
MCF	O
-	I:C0596890
7	I:C0596890
breast	O
tumor	I:C1458155
animal	O
models	I:C0012644
for	O
24	O
h	O
.	O

Moreover	O
,	O
the	O
tumor	O
accumulation	B:C4055506
of	O
the	O
GNS	O
-	O
pHLIP	O
was	O
3	O
-	O
fold	O
higher	O
than	O
that	O
of	O
GNS	O
-	O
mPEG	O
after	O
intravenous	O
injection	O
into	O
MCF	O
-	I:C0596890
7	I:C0596890
breast	O
tumor	I:C1458155
animal	O
models	I:C0012644
for	O
24	O
h	O
.	O

Moreover	O
,	O
the	O
tumor	O
accumulation	O
of	O
the	O
GNS	B:C0018026
-	O
pHLIP	O
was	O
3	O
-	O
fold	O
higher	O
than	O
that	O
of	O
GNS	O
-	O
mPEG	O
after	O
intravenous	O
injection	O
into	O
MCF	O
-	I:C0596890
7	I:C0596890
breast	O
tumor	I:C1458155
animal	O
models	I:C0012644
for	O
24	O
h	O
.	O

Moreover	O
,	O
the	O
tumor	O
accumulation	O
of	O
the	O
GNS	O
-	O
pHLIP	B:C2606266
was	O
3	O
-	O
fold	O
higher	O
than	O
that	O
of	O
GNS	O
-	O
mPEG	O
after	O
intravenous	O
injection	O
into	O
MCF	O
-	I:C0596890
7	I:C0596890
breast	O
tumor	I:C1458155
animal	O
models	I:C0012644
for	O
24	O
h	O
.	O

Moreover	O
,	O
the	O
tumor	O
accumulation	O
of	O
the	O
GNS	O
-	O
pHLIP	O
was	O
3	O
-	O
fold	O
higher	O
than	O
that	O
of	O
GNS	B:C0018026
-	O
mPEG	O
after	O
intravenous	O
injection	O
into	O
MCF	O
-	I:C0596890
7	I:C0596890
breast	O
tumor	I:C1458155
animal	O
models	I:C0012644
for	O
24	O
h	O
.	O

Moreover	O
,	O
the	O
tumor	O
accumulation	O
of	O
the	O
GNS	O
-	O
pHLIP	O
was	O
3	O
-	O
fold	O
higher	O
than	O
that	O
of	O
GNS	O
-	O
mPEG	B:C0066763
after	O
intravenous	O
injection	O
into	O
MCF	O
-	I:C0596890
7	I:C0596890
breast	O
tumor	I:C1458155
animal	O
models	I:C0012644
for	O
24	O
h	O
.	O

Moreover	O
,	O
the	O
tumor	O
accumulation	O
of	O
the	O
GNS	O
-	O
pHLIP	O
was	O
3	O
-	O
fold	O
higher	O
than	O
that	O
of	O
GNS	O
-	O
mPEG	O
after	O
intravenous	O
injection	O
into	O
MCF	B:C0596890
-	I:C0596890
7	I:C0596890
breast	O
tumor	I:C1458155
animal	O
models	I:C0012644
for	O
24	O
h	O
.	O

Moreover	O
,	O
the	O
tumor	O
accumulation	O
of	O
the	O
GNS	O
-	O
pHLIP	O
was	O
3	O
-	O
fold	O
higher	O
than	O
that	O
of	O
GNS	O
-	O
mPEG	O
after	O
intravenous	O
injection	O
into	O
MCF	O
-	I:C0596890
7	I:C0596890
breast	B:C1458155
tumor	I:C1458155
animal	O
models	I:C0012644
for	O
24	O
h	O
.	O

Moreover	O
,	O
the	O
tumor	O
accumulation	O
of	O
the	O
GNS	O
-	O
pHLIP	O
was	O
3	O
-	O
fold	O
higher	O
than	O
that	O
of	O
GNS	O
-	O
mPEG	O
after	O
intravenous	O
injection	O
into	O
MCF	O
-	I:C0596890
7	I:C0596890
breast	O
tumor	I:C1458155
animal	B:C0012644
models	I:C0012644
for	O
24	O
h	O
.	O

Furthermore	O
,	O
GNS	B:C0018026
-	O
pHLIP	O
exhibited	O
stronger	O
signals	O
than	O
the	O
GNS	O
-	O
mPEG	O
through	O
computed	O
tomography	I:C0040405
(	O
computed	O
tomography	I:C0040405
)	O
and	O
photoacoustic	O
(	I:C3897929
PA	I:C3897929
)	I:C3897929
imaging	I:C3897929
.	O

Furthermore	O
,	O
GNS	O
-	O
pHLIP	B:C2606266
exhibited	O
stronger	O
signals	O
than	O
the	O
GNS	O
-	O
mPEG	O
through	O
computed	O
tomography	I:C0040405
(	O
computed	O
tomography	I:C0040405
)	O
and	O
photoacoustic	O
(	I:C3897929
PA	I:C3897929
)	I:C3897929
imaging	I:C3897929
.	O

Furthermore	O
,	O
GNS	O
-	O
pHLIP	O
exhibited	O
stronger	O
signals	O
than	O
the	O
GNS	B:C0018026
-	O
mPEG	O
through	O
computed	O
tomography	I:C0040405
(	O
computed	O
tomography	I:C0040405
)	O
and	O
photoacoustic	O
(	I:C3897929
PA	I:C3897929
)	I:C3897929
imaging	I:C3897929
.	O

Furthermore	O
,	O
GNS	O
-	O
pHLIP	O
exhibited	O
stronger	O
signals	O
than	O
the	O
GNS	O
-	O
mPEG	B:C0066763
through	O
computed	O
tomography	I:C0040405
(	O
computed	O
tomography	I:C0040405
)	O
and	O
photoacoustic	O
(	I:C3897929
PA	I:C3897929
)	I:C3897929
imaging	I:C3897929
.	O

Furthermore	O
,	O
GNS	O
-	O
pHLIP	O
exhibited	O
stronger	O
signals	O
than	O
the	O
GNS	O
-	O
mPEG	O
through	O
computed	B:C0040405
tomography	I:C0040405
(	O
computed	O
tomography	I:C0040405
)	O
and	O
photoacoustic	O
(	I:C3897929
PA	I:C3897929
)	I:C3897929
imaging	I:C3897929
.	O

Furthermore	O
,	O
GNS	O
-	O
pHLIP	O
exhibited	O
stronger	O
signals	O
than	O
the	O
GNS	O
-	O
mPEG	O
through	O
computed	O
tomography	I:C0040405
(	O
computed	B:C0040405
tomography	I:C0040405
)	O
and	O
photoacoustic	O
(	I:C3897929
PA	I:C3897929
)	I:C3897929
imaging	I:C3897929
.	O

Furthermore	O
,	O
GNS	O
-	O
pHLIP	O
exhibited	O
stronger	O
signals	O
than	O
the	O
GNS	O
-	O
mPEG	O
through	O
computed	O
tomography	I:C0040405
(	O
computed	O
tomography	I:C0040405
)	O
and	O
photoacoustic	B:C3897929
(	I:C3897929
PA	I:C3897929
)	I:C3897929
imaging	I:C3897929
.	O

Simultaneously	O
,	O
the	O
desirable	O
targeting	O
efficiency	O
significantly	O
improved	O
the	O
photothermal	B:C0454527
therapeutic	I:C0454527
efficacy	O
to	O
tumors	O
,	O
with	O
low	O
side	O
effects	I:C0879626
on	O
normal	O
tissues	O
.	O

Simultaneously	O
,	O
the	O
desirable	O
targeting	O
efficiency	O
significantly	O
improved	O
the	O
photothermal	O
therapeutic	I:C0454527
efficacy	O
to	O
tumors	B:C0027651
,	O
with	O
low	O
side	O
effects	I:C0879626
on	O
normal	O
tissues	O
.	O

Simultaneously	O
,	O
the	O
desirable	O
targeting	O
efficiency	O
significantly	O
improved	O
the	O
photothermal	O
therapeutic	I:C0454527
efficacy	O
to	O
tumors	O
,	O
with	O
low	O
side	B:C0879626
effects	I:C0879626
on	O
normal	O
tissues	O
.	O

Simultaneously	O
,	O
the	O
desirable	O
targeting	O
efficiency	O
significantly	O
improved	O
the	O
photothermal	O
therapeutic	I:C0454527
efficacy	O
to	O
tumors	O
,	O
with	O
low	O
side	O
effects	I:C0879626
on	O
normal	O
tissues	B:C0040300
.	O

The	O
results	O
clearly	O
demonstrate	O
that	O
the	O
GNS	B:C0018026
-	O
pHLIP	O
successfully	O
took	O
advantage	O
of	O
the	O
tumor	O
-	O
targeting	O
ability	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
and	O
the	O
good	O
characteristics	O
of	O
GNS	O
s	I:C0018026
,	O
which	O
may	O
contribute	O
to	O
the	O
study	O
of	O
tumor	O
imaging	O
and	O
therapy	O
.	O

The	O
results	O
clearly	O
demonstrate	O
that	O
the	O
GNS	O
-	O
pHLIP	B:C2606266
successfully	O
took	O
advantage	O
of	O
the	O
tumor	O
-	O
targeting	O
ability	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
and	O
the	O
good	O
characteristics	O
of	O
GNS	O
s	I:C0018026
,	O
which	O
may	O
contribute	O
to	O
the	O
study	O
of	O
tumor	O
imaging	O
and	O
therapy	O
.	O

The	O
results	O
clearly	O
demonstrate	O
that	O
the	O
GNS	O
-	O
pHLIP	O
successfully	O
took	O
advantage	O
of	O
the	O
tumor	B:C0027651
-	O
targeting	O
ability	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
and	O
the	O
good	O
characteristics	O
of	O
GNS	O
s	I:C0018026
,	O
which	O
may	O
contribute	O
to	O
the	O
study	O
of	O
tumor	O
imaging	O
and	O
therapy	O
.	O

The	O
results	O
clearly	O
demonstrate	O
that	O
the	O
GNS	O
-	O
pHLIP	O
successfully	O
took	O
advantage	O
of	O
the	O
tumor	O
-	O
targeting	O
ability	O
of	O
pH	B:C2606266
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
and	O
the	O
good	O
characteristics	O
of	O
GNS	O
s	I:C0018026
,	O
which	O
may	O
contribute	O
to	O
the	O
study	O
of	O
tumor	O
imaging	O
and	O
therapy	O
.	O

The	O
results	O
clearly	O
demonstrate	O
that	O
the	O
GNS	O
-	O
pHLIP	O
successfully	O
took	O
advantage	O
of	O
the	O
tumor	O
-	O
targeting	O
ability	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
and	O
the	O
good	O
characteristics	O
of	O
GNS	B:C0018026
s	I:C0018026
,	O
which	O
may	O
contribute	O
to	O
the	O
study	O
of	O
tumor	O
imaging	O
and	O
therapy	O
.	O

The	O
results	O
clearly	O
demonstrate	O
that	O
the	O
GNS	O
-	O
pHLIP	O
successfully	O
took	O
advantage	O
of	O
the	O
tumor	O
-	O
targeting	O
ability	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
and	O
the	O
good	O
characteristics	O
of	O
GNS	O
s	I:C0018026
,	O
which	O
may	O
contribute	O
to	O
the	O
study	O
of	O
tumor	B:C0027651
imaging	O
and	O
therapy	O
.	O

The	O
results	O
clearly	O
demonstrate	O
that	O
the	O
GNS	O
-	O
pHLIP	O
successfully	O
took	O
advantage	O
of	O
the	O
tumor	O
-	O
targeting	O
ability	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
and	O
the	O
good	O
characteristics	O
of	O
GNS	O
s	I:C0018026
,	O
which	O
may	O
contribute	O
to	O
the	O
study	O
of	O
tumor	O
imaging	B:C0011923
and	O
therapy	O
.	O

The	O
results	O
clearly	O
demonstrate	O
that	O
the	O
GNS	O
-	O
pHLIP	O
successfully	O
took	O
advantage	O
of	O
the	O
tumor	O
-	O
targeting	O
ability	O
of	O
pH	O
(	I:C2606266
low	I:C2606266
)	I:C2606266
insertion	I:C2606266
peptides	I:C2606266
and	O
the	O
good	O
characteristics	O
of	O
GNS	O
s	I:C0018026
,	O
which	O
may	O
contribute	O
to	O
the	O
study	O
of	O
tumor	O
imaging	O
and	O
therapy	B:C0087111
.	O

